The journal
Bond sales, buy-backs and a queue of tariffs
Economists press the Bank of England to stop selling gilts while Washington's debt management draws sceptics, and Canada answers US duties with tariffs of up to 50%.
The debt question, asked twice
City A.M. reported this morning that economists are urging the Bank of England to halt its bond sales, with climbing borrowing costs given as the reason. The call concerns the Bank's own disposals rather than its policy rate.
Across the Atlantic the same subject arrived in a different register. The Guardian asked whether the Trump Treasury is panicking over the level of US debt. CNBC reported that Stanley Druckenmiller leads a group of doubters who think Treasury Secretary Scott Bessent's bond ploys will fail. The South China Morning Post's read on the Treasury's bond buy-back was that it reinforces the gold debasement trade, with the Jackson Hole meeting looming over the week.
Gold itself moved both ways inside twenty-four hours. On Tuesday morning This is Money had the metal rising and bitcoin at a three-month high, framing both as investors backing away from US assets. By the small hours of Wednesday the Wall Street Journal reported gold slipping as markets waited for the Fed chairman's comments at Jackson Hole.
The Journal also ran a piece asking whether inflation-fighting bonds are on sale — the question posed of Treasury inflation-protected securities rather than answered on the reader's behalf. Nearer home, the state pension was the subject of a warning to Healey, reported by City A.M., that the bill will pile pain on the next generation of taxpayers. And in Jersey, official figures showed earnings up 1.2% after inflation.
Canada answers, and shares rise anyway
Mark Carney announced retaliatory tariffs of up to 50% on hundreds of US imports, covering some $20bn of goods, in a step reported by the Guardian, Euronews and Sky News as an escalation of the trade war. Canada's measures span a wide range of American products.
Equity markets spent Tuesday looking elsewhere. The Journal's live coverage had stocks advancing and oil dropping as investors pinned hopes on diplomacy, and its close-of-day report attributed the rise in US shares to retreating oil and inflation fears. This is Money, meanwhile, reported Bessent launching what it called an economic onslaught on Iran.
In London the FTSE 100 crept closer to its record high, which City A.M. put down to investors dodging the turmoil in artificial intelligence shares. Tokyo did not join in: the Nikkei fell 0.4%, dragged by chip-related stocks, according to the Journal.
Single names supplied the rest of the London tape. Housebuilder shares soared on Andy Burnham's council housing plans. The UK government took a stake in a miner after a £71m injection. GSK shares drifted despite a boost from drug approvals. A top FTSE headhunter fell into administration and was rescued by a rival.
Canada's banks reported through the tariff news. Bank of Montreal said it plans to buy back shares after a strong quarter, with earnings hit by a charge. Scotiabank's results were lifted by a record showing in wealth management. In Hong Kong, WuXi Biologics posted a 4.3% rise in first-half profit, described by the South China Morning Post as defying biotech headwinds.
A lengthening queue at the door
The IPO pipeline is filling. The Journal reported that Oura and Dunkin' are eyeing offerings as Wall Street's listing boom builds. City A.M., on the same day, published a piece arguing investors should not rush to buy the next blockbuster debut.
In China, DeepSeek is nearing a pre-IPO funding round, with sources telling the South China Morning Post that a 2027 market debut is taking shape. The scale of the ambitions being sold to private investors was set out by the Journal, which reported Anthropic is expected to tell backers it sees over $30 trillion in potential revenue.
London's small-cap market has its own scheme. City A.M. asked whether the Capital Access Window can finally revive AIM.
Two stories sat awkwardly beside the enthusiasm. Regulators are probing the near-collapse of the hedge fund Situational Awareness, the Journal reported. And S&P warned that heatwave health risks threaten insurer earnings in Europe, according to the Guardian.
At the retail end, James Watt launched a hangover drink and offered the first 20,000 customers a stake in it, as reported by This is Money. Elsewhere in the day's odder corners: a group of Bayern Munich old boys took over a Portuguese top-flight club, and the Guardian filmed an inquiry into who really profits when sardines go viral.
Sources
- Economists urge Bank of England to halt bond sales as borrowing costs climb (opens in a new tab) · City A.M.
- Why investors shouldn’t rush to buy the next blockbuster IPO (opens in a new tab) · City A.M.
- Are Inflation-Fighting Bonds on Sale? (opens in a new tab) · WSJ Markets
- Jersey earnings rise by 1.2% after inflation (opens in a new tab) · BBC Business
- FTSE 100 creeps closer to record high as investors dodge AI turmoil (opens in a new tab) · City A.M.
- Oura and Dunkin’ Eye Offerings as Wall Street’s IPO Boom Builds (opens in a new tab) · WSJ Markets
- Stock Market News, Aug. 25, 2026: Stocks Advance, Oil Drops as Investors Pin Hopes on Diplomacy (opens in a new tab) · WSJ Markets
- US Treasury bond buy-back reinforces gold debasement trade as Jackson Hole meeting looms (opens in a new tab) · SCMP Business
- DeepSeek nears pre-IPO funding round as 2027 market debut takes shape: sources (opens in a new tab) · SCMP Business
- Is the Trump Treasury panicking over the level of US debt? (opens in a new tab) · The Guardian Business
- Gold Slips as Markets Await Fed Chairman Comments at Jackson Hole (opens in a new tab) · WSJ Markets
- Nikkei Falls 0.4%, Dragged by Chip-Related Stocks (opens in a new tab) · WSJ Markets
- State pension set to pile pain on next generation of taxpayers, Healey warned (opens in a new tab) · City A.M.
- U.S. Stocks Rise as Oil, Inflation Fears Retreat (opens in a new tab) · WSJ Markets
- Canada announces retaliatory tariffs on wide range of US goods (opens in a new tab) · The Guardian Business
- Anthropic Expected to Tell Investors It Sees Over $30 Trillion in Potential Revenue (opens in a new tab) · WSJ Markets
- Canada hits back with tariffs of up to 50% on US goods as trade war escalates (opens in a new tab) · Euronews Business
- James Watt launches hangover drink - and the first 20,000 customers can own a stake in it (opens in a new tab) · This is Money Markets
- Bank of Montreal Plans to Buy Back Shares After Strong Quarter (opens in a new tab) · WSJ Markets
- Canada announces tariffs on $20bn worth of US goods (opens in a new tab) · Sky News Business
- Regulators Probing Near-Collapse of Hedge Fund Situational Awareness (opens in a new tab) · WSJ Markets
- Top FTSE headhunter rescued by rival after plunging into administration (opens in a new tab) · City A.M.
- Can the Capital Access Window finally revive AIM? (opens in a new tab) · City A.M.
- WuXi Biologics posts 4.3% rise in first-half profit, defying biotech headwinds (opens in a new tab) · SCMP Business
- Bayern Munich old boys in takeover of Portuguese top-flight club (opens in a new tab) · City A.M.
- Scotiabank Earnings Lifted by Record Result in Wealth Management (opens in a new tab) · WSJ Markets
- Fishy business: who really profits when sardines go viral? - video (opens in a new tab) · The Guardian Business
- Bitcoin hits three-month high and gold price rises as investors back away from US assets (opens in a new tab) · This is Money Markets
- Heatwave health risks threaten insurer earnings, rating agency S&P warns (opens in a new tab) · The Guardian Business
- Housebuilder shares soar on Burnham council housing plans (opens in a new tab) · City A.M.
- UK government takes stake in miner after £71m injection (opens in a new tab) · City A.M.
- GSK shares drift despite drug approvals boost (opens in a new tab) · This is Money Markets
- US Treasury Secretary Scott Bessent launches 'economic onslaught' on Iran (opens in a new tab) · This is Money Markets
This article is for general information only and does not constitute financial advice.